相似文献
1
Approaches to the treatment of disease induced by chikungunya virus.
Indian J Med Res. 2013 Nov;138(5):762-5.
2
Chikungunya: a re-emerging virus.
Lancet. 2012 Feb 18;379(9816):662-71. doi: 10.1016/S0140-6736(11)60281-X. Epub 2011 Nov 17.
3
Infectious diseases. Chikungunya: no longer a third world disease.
Science. 2007 Dec 21;318(5858):1860-1. doi: 10.1126/science.318.5858.1860.
4
[Chikungunya fever--expanded distribution of a re-emerging tropical infectious disease].
Med Monatsschr Pharm. 2009 Jan;32(1):17-26.
5
Outbreak and spread of chikungunya.
Wkly Epidemiol Rec. 2007 Nov 23;82(47):409-15.
6
Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk.
J Clin Virol. 2015 Mar;64:144-52. doi: 10.1016/j.jcv.2014.08.032. Epub 2014 Oct 22.
7
How great is the threat of chikungunya virus?
Expert Rev Anti Infect Ther. 2015 Mar;13(3):291-3. doi: 10.1586/14787210.2015.995634. Epub 2014 Dec 24.
8
Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.
Antiviral Res. 2013 Sep;99(3):345-70. doi: 10.1016/j.antiviral.2013.06.009. Epub 2013 Jun 28.
9
Chikungunya: an overview.
J Biosci. 2008 Nov;33(4):443-9. doi: 10.1007/s12038-008-0063-2.
10
Chikungunya virus in the Americas--what a vectorborne pathogen can do.
N Engl J Med. 2014 Sep 4;371(10):887-9. doi: 10.1056/NEJMp1407698.
引用本文的文献
1
Cracking the code: ET-1 signaling unlocks new therapies for virus-induced osteoarthritis.
Npj Viruses. 2024 Oct 21;2(1):50. doi: 10.1038/s44298-024-00064-y.
2
Alphavirus nsP2: A Multifunctional Regulator of Viral Replication and Promising Target for Anti-Alphavirus Therapies.
Rev Med Virol. 2025 Mar;35(2):e70030. doi: 10.1002/rmv.70030.
3
Exploring Barmah Forest virus pathogenesis: molecular tools to investigate non-structural protein 3 nuclear localization and viral genomic determinants of replication.
mBio. 2024 Aug 14;15(8):e0099324. doi: 10.1128/mbio.00993-24. Epub 2024 Jul 2.
4
FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design.
Nat Commun. 2023 Oct 26;14(1):6605. doi: 10.1038/s41467-023-42330-2.
5
Role of MXRA8 in Ross River Virus Disease Pathogenesis.
mBio. 2023 Apr 25;14(2):e0058823. doi: 10.1128/mbio.00588-23. Epub 2023 Apr 10.
6
N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.
J Virol. 2022 Sep 14;96(17):e0099922. doi: 10.1128/jvi.00999-22. Epub 2022 Aug 24.
7
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687. doi: 10.1093/cvr/cvaa106.
8
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.
Viruses. 2018 May 17;10(5):268. doi: 10.3390/v10050268.
9
Selected mosquito-borne illnesses-Chikungunya.
Dis Mon. 2018 May;64(5):222-234. doi: 10.1016/j.disamonth.2018.01.009. Epub 2018 Mar 9.
10
Establishment of a Novel Primary Human Skeletal Myoblast Cellular Model for Chikungunya Virus Infection and Pathogenesis.
Sci Rep. 2016 Feb 19;6:21406. doi: 10.1038/srep21406.
本文引用的文献
1
Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus.
Antiviral Res. 2013 Apr;98(1):12-8. doi: 10.1016/j.antiviral.2013.01.002. Epub 2013 Feb 1.
2
Identification of a candidate therapeutic autophagy-inducing peptide.
Nature. 2013 Feb 14;494(7436):201-6. doi: 10.1038/nature11866. Epub 2013 Jan 30.
3
Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
Antimicrob Agents Chemother. 2013 Jan;57(1):155-67. doi: 10.1128/AAC.01467-12. Epub 2012 Oct 22.
4
Chikungunya virus and prospects for a vaccine.
Expert Rev Vaccines. 2012 Sep;11(9):1087-101. doi: 10.1586/erv.12.84.
5
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.
J Virol. 2013 Jan;87(1):395-402. doi: 10.1128/JVI.01860-12. Epub 2012 Oct 17.
6
Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication.
PLoS One. 2012;7(10):e46396. doi: 10.1371/journal.pone.0046396. Epub 2012 Oct 8.
7
Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis.
Arthritis Rheum. 2012 Nov;64(11):3553-63. doi: 10.1002/art.34631.
8
Mannose binding lectin is required for alphavirus-induced arthritis/myositis.
PLoS Pathog. 2012;8(3):e1002586. doi: 10.1371/journal.ppat.1002586. Epub 2012 Mar 22.
9
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
PLoS One. 2011;6(12):e28923. doi: 10.1371/journal.pone.0028923. Epub 2011 Dec 19.
10
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis.
J Infect Dis. 2011 Oct 1;204(7):1026-30. doi: 10.1093/infdis/jir470.
Zotero 插件